Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Mind Medicine Inc’s stock clocked out at $6.78, down -2.02% from its previous closing price of $6.92. In other words, the price has decreased by -$2.02 from its previous closing price. On the day, 1.04 million shares were traded. MNMD stock price reached its highest trading level at $6.9726 during the session, while it also had its lowest trading level at $6.67.
Ratios:
To gain a deeper understanding of MNMD’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.00 and its Current Ratio is at 7.20. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on January 28, 2025, initiated with a Outperform rating and assigned the stock a target price of $23.
On December 20, 2024, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 25 ’25 when MARK SULLIVAN bought 6,576 shares for $6.74 per share.
CARRIE LIAO bought 2,347 shares of MNMD for $15,812 on Mar 25 ’25. On Mar 25 ’25, another insider, ROBERT B BARROW, who serves as the Officer of the company, bought 21,208 shares for $6.74 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 510997760 and an Enterprise Value of 259110480.
Stock Price History:
The Beta on a monthly basis for MNMD is 2.36, which has changed by -0.2863158 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, MNMD has reached a high of $12.22, while it has fallen to a 52-week low of $5.03. The 50-Day Moving Average of the stock is -5.87%, while the 200-Day Moving Average is calculated to be -3.77%.
Shares Statistics:
It appears that MNMD traded 2.01M shares on average per day over the past three months and 1024730 shares per day over the past ten days. A total of 75.37M shares are outstanding, with a floating share count of 74.05M. Insiders hold about 1.20% of the company’s shares, while institutions hold 49.60% stake in the company. Shares short for MNMD as of 1741910400 were 11372547 with a Short Ratio of 5.88, compared to 1739491200 on 10885373. Therefore, it implies a Short% of Shares Outstanding of 11372547 and a Short% of Float of 15.100000999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The stock of Mind Medicine Inc (MNMD) is currently drawing attention from 7.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.39, with high estimates of -$0.35 and low estimates of -$0.41.
Analysts are recommending an EPS of between -$1.44 and -$1.7 for the fiscal current year, implying an average EPS of -$1.61. EPS for the following year is -$1.77, with 6.0 analysts recommending between -$1.47 and -$1.95.
